A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 16,151 shares of ABT stock, worth $1.85 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
16,151
Previous 28,510 43.35%
Holding current value
$1.85 Million
Previous $2.96 Million 37.85%
% of portfolio
0.07%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$100.07 - $118.13 $1.24 Million - $1.46 Million
-12,359 Reduced 43.35%
16,151 $1.84 Million
Q2 2024

Jul 11, 2024

SELL
$100.73 - $112.44 $99,823 - $111,428
-991 Reduced 3.36%
28,510 $2.96 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $353,530 - $390,458
-3,228 Reduced 9.86%
29,501 $3.35 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $1.21 Million - $1.49 Million
13,461 Added 69.86%
32,729 $3.6 Million
Q3 2023

Oct 19, 2023

SELL
$95.53 - $114.62 $382 - $458
-4 Reduced 0.02%
19,268 $1.87 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $70,949 - $79,052
704 Added 3.79%
19,272 $2.1 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $41,843 - $49,252
432 Added 2.38%
18,568 $1.88 Million
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $76,713 - $89,996
-807 Reduced 4.26%
18,136 $1.99 Million
Q3 2022

Nov 01, 2022

SELL
$96.76 - $112.03 $12,675 - $14,675
-131 Reduced 0.69%
18,943 $1.83 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $43,685 - $52,802
428 Added 2.3%
19,074 $2.07 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $58,150 - $70,910
510 Added 2.81%
18,646 $2.21 Million
Q4 2021

Jan 21, 2022

SELL
$115.53 - $141.46 $243,537 - $298,197
-2,108 Reduced 10.41%
18,136 $2.55 Million
Q3 2021

Nov 01, 2021

BUY
$116.66 - $129.06 $2.36 Million - $2.61 Million
20,244 New
20,244 $2.39 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.